NEOG - NEOGEN CORP
9.42
-0.210 -2.229%
Share volume: 2,546,597
Last Updated: 04-21-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
0.23%
PREVIOUS CLOSE
CHG
CHG%
$9.63
-0.21
-0.02%
View ratios
| Fiscal Date | 05-31-2024 | 08-31-2024 | 11-30-2024 | 02-28-2025 | 05-31-2025 | 08-31-2025 | 11-30-2025 | 02-28-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2024 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
| Report Date | 01-15-2025 | 10-10-2024 | 01-15-2025 | 04-09-2025 | 07-30-2025 | 10-09-2025 | 01-08-2026 | 04-09-2026 | |
| Assets | |||||||||
| Total Assets | 4.549 B | 4.503 B | 4.054 B | 4.036 B | 3.444 B | 3.378 B | 3.360 B | 3.359 B | |
| Current Assets | 589.233 M | 540.650 M | 570.447 M | 551.713 M | 576.937 M | 524.060 M | 574.576 M | 590.000 M | |
| Inventories | 189.267 M | 198.596 M | 198.267 M | 205.442 M | 190.859 M | 193.414 M | 162.766 M | 161.700 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 325.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 170.611 M | 120.477 M | 140.231 M | 127.705 M | 129.004 M | 138.883 M | 145.340 M | 159.900 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 277.104 M | 300.971 M | 310.552 M | 327.838 M | 339.131 M | 345.893 M | 332.362 M | 331.900 M | |
| Other Assets | 3.682 B | 3.662 B | 3.173 B | 3.157 B | 2.528 B | 2.508 B | 2.453 B | 2.437 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 4.549 B | 4.503 B | 4.054 B | 4.036 B | 3.444 B | 3.378 B | 3.360 B | 3.359 B | |
| Total liabilities | 1.405 B | 1.368 B | 1.385 B | 1.376 B | 1.373 B | 1.260 B | 1.255 B | 1.257 B | |
| Total current liabilities | 154.323 M | 122.689 M | 151.195 M | 141.200 M | 174.011 M | 146.205 M | 147.050 M | 150.600 M | |
| Accounts Payable | 83.061 M | 61.464 M | 79.574 M | 72.240 M | 79.605 M | 76.596 M | 63.040 M | 75.200 M | |
| Other liabilities | 35.259 M | 38.589 M | 41.555 M | 43.131 M | 42.854 M | 43.519 M | 41.542 M | 43.500 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 888.391 M | 889.129 M | 889.867 M | 890.605 M | 874.810 M | 792.530 M | 792.926 M | 793.300 M | |
| Other liabilities | 35.259 M | 38.589 M | 41.555 M | 43.131 M | 42.854 M | 43.519 M | 41.542 M | 43.500 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 3.144 B | 3.135 B | 2.669 B | 2.660 B | 2.071 B | 2.119 B | 2.104 B | 2.102 B | |
| Common stock | 2.619 B | 2.624 B | 2.627 B | 2.632 B | 2.637 B | 2.642 B | 2.646 B | 2.648 B | |
| Retained earnings | 555.620 M | 543.011 M | 86.729 M | 75.772 M | -536.424 M | -500.086 M | -516.010 M | -533.000 M |